Innate Therapeutics Receives Funding For Clinical Trial Of Progressive Multiple Sclerosis Therapeutic
Links shared publicly online about this topic.
- 1,186total visits
Innate Therapeutics Receives Funding For Clinical Trial Of Progressive Multiple Sclerosis Therapeutic
View full resource at medicalnewstoday.com
Tags: Multiple Sclerosis, Clinical Trial
Most Recently Shared on May 7, 2010 at 9:45 pm By:
Innate Therapeutics Receives Funding For Clinical Trial Of Progressive Multiple Sclerosis Therapeutic: Innate Ther... http://mnt.to/f/3ChS
Also Shared By:
Innate Therapeutics receives funding to conduct Phase 2A clinical trial for MIS416
news-medical.net — “Innate Therapeutics today announced funding support from Fast Forward, LLC, a not-for-profit organization established by the U.S. National Multiple Sclerosis Society and EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany. The award of funds will help support the conduct of a Phase 2A clinical trial in patients with progressive forms of MS using MIS416, a naturally occurring agent derived from bacteria.” View full resource at news-medical.net
Most Recently Shared on May 6, 2010 at 5:36 am By:
Innate Therapeutics receives funding to conduct Phase 2A clinical trial for MIS416: Innate Therapeutics today anno... http://bit.ly/aTQV9U
Advertisement
MNT Multiple Scl
@mnt_multiplescl
Innate Therapeutics Receives Funding For Clinical Trial Of Progressive Multiple Sclerosis Therapeutic http://mnt.to/3ChS #multiplesclerosis
1 year ago...